Ready for enrolment of Episealer® patients in the US
Episurf Medical (NASDAQ: EPIS B) announces that the EPIC-Knee Episealer® Knee System IDE Clinical Study is ready for enrolment of patients as the first clinical trial agreement is now fully executed with a hospital in Texas, USA. Episurf Medical is in the very final stages of contract negotiations with several other US hospitals and the study will, apart from the US sites, include participants in three European countries. Episurf Medical has identified the desired study sites and have advanced far in the set-up process, yet, the study allows for additional sites should the company want to